Table 4.
Reduction in HbA1c and LDL Levels in Case-Managed versus Reference Patients
| HbA1c | LDL | ||||||
|---|---|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | ||||||
| Baseline | Post | Reduction | Adj. Reduction | Baseline | Post | Reduction | |
| Care management | 7.96 (1.74) | 7.41 (1.38) | 0.55% | −0.46% | 102.8 (32.7) | 96.7 (28.3) | −6.1 mg/dl |
| Reference | 7.71 (1.53) | 7.53 (1.36) | 0.18% | −0.18%† | 104.3 (33.2) | 100.6 (30.4) | −3.7 mg/dl |
| Difference | 0.25 | (−0.12) | (−0.37) | (−0.28) | (−1.5) | (−3.9) | (−2.4 mg/dl) |
| p-value | <.01 | .02 | <.001 | <.01 | NS | <.01 | .09 |
*
Adjusted for regression to the mean; for details, see Davis (1976) or Trochim (2003).
†
The baseline value for the lower mean does not change in the method.
HbAlc, glycosylated hemoglobin; LDL, low-density lipoprotein.